24 Followers on Owler
OverviewCompetitorsAcquisitionsNews & Insights

BioreclamationIVT Competitors or Alternatives

BioreclamationIVT's top competitors include Conversant Bio, THB and Cureline.

Unlock 10 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

BioreclamationIVT's company profile

Jeff Gatz

CEO

64/100
25 - 100
$0
$5M - 25M
  • $0
    $5M - 25M
  • 25 - 100
    $0
  • $5M - 25M
  • 64/100
  • 25 - 100
  • $0
  • $5M - 25M
View ProfileView
1
BioreclamationIVT's Competitor - Conversant Bio logo

Marshall Schreeder

Co-Founder & CEO

83/100
100 - 250
- -
$5M - 25M
  • - -
    $5M - 25M
  • 100 - 250
    - -
  • $5M - 25M
  • 83/100
  • 100 - 250
  • - -
  • $5M - 25M
View ProfileView
2
BioreclamationIVT's Competitor - THB logo

Pascal Puchois

Founder & CEO

84/100
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • 84/100
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
3
BioreclamationIVT's Competitor - Cureline logo

Olga Potapova

Founder & CEO

82/100
1 - 25
$150K
$5M - 25M
  • $150K
    $5M - 25M
  • 1 - 25
    $150K
  • $5M - 25M
  • 82/100
  • 1 - 25
  • $150K
  • $5M - 25M
View ProfileView
4
BioreclamationIVT's Competitor - Tissue Solutions logo

Morag McFarlane

CEO

75/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 75/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
5
BioreclamationIVT's Competitor - Antibodies, Inc. logo

CEO

- -
100 - 250
- -
$25M - 100M
  • - -
    $25M - 100M
  • 100 - 250
    - -
  • $25M - 100M
  • - -
  • 100 - 250
  • - -
  • $25M - 100M
View ProfileView
BioreclamationIVT's top 13 competitors are Conversant Bio, THB, Cureline, AllCells, Tissue Solutions, Antibodies, Inc., BIO|OPTIONS, Gilead, United Therapeutics, Pfizer, Provia Labs, AutoGen and Regeneron. Together they have raised over 10.7B between their estimated 113.4K employees. BioreclamationIVT's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 7.8B. BioreclamationIVT has 66 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 8,102.

BioreclamationIVT VS THB

THB is seen as one of BioreclamationIVT's top competitors. THB was founded in 2009, and its headquarters is in Laval, Quebec. THB operates in the Biotechnology industry. THB has 26 fewer employees than BioreclamationIVT.

Looking for similar companies to BioreclamationIVT?

Similar Companies

Health Care Equipment & Services companies in Hicksville

See 68 companies 
Companies in Hicksville with revenue in $5.0-25M range

See 420 companies 
Health Care Equipment companies in New York

See 907 companies 
Companies in Hicksville with employees in 25-100 range

See 547 companies 
Health Care Equipment companies in New York Metropolitan Area

See 1,012 companies 
Health Care Equipment companies with employees in 25-100 range

See 7,115 companies 
Health Care Equipment companies with revenue in $5.0-25M range

See 7,210 companies 
Health Care Equipment companies in USA

See 15,685 companies 
Health Care Equipment companies in North America

See 17,081 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for BioreclamationIVT and BioreclamationIVT's Competitors

April 25, 2025Yahoo
In This Article: Gilead Sciences, Inc . GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed...
April 25, 2025Commercial Observer
George Yancopoulos, co-founder of biotech company Regeneron, has purchased almost all of the condominium units in a mixed-use Tribeca building, accordi...
April 24, 2025Benzinga
Guardant Health, Inc. GH on Thursday announced a strategic collaboration with Pfizer, Inc. PFE to support the development and commercialization of Pfiz...
April 24, 2025The San Diego Union Tribune
The gene sequencing giant will lose 172 employees, on top of recently announced layoffs totaling 96 workers....
April 25, 2025Nasdaq
Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either. After publishing its earnings report aft...
April 25, 2025Reuters
Gilead Sciences (GILD.O), opens new tab on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver d...
April 24, 2025PMLiVE
Triple-negative breast cancer accounts for approximately 15% of all cases of the disease...
April 24, 2025Marketscreener
(Reuters) -Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver disease, along...
April 24, 202524/7 Wall St.
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. R...
April 25, 2025Pharmabiz
Pfizer Inc. will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical Oncology (ASCO)...

Frequently Asked Questions about BioreclamationIVT

  1. Who are BioreclamationIVT's top competitors?

    BioreclamationIVT's top 3 competitors are Conversant Bio, THB, Cureline.

  2. Who is similar to BioreclamationIVT?

    Conversant Bio is the most similar to BioreclamationIVT. THB and Cureline are also similar to BioreclamationIVT.

  1. Are BioreclamationIVT and Conversant Bio competitors?

    Yes, Conversant Bio is one of BioreclamationIVT’s top competitors.